Intranet
Guillaume Lingas | IAME
Guillaume Lingas Position: Permanent researcher / CR Affiliation: Inserm
Team: MOCLID

Publications

Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis

2024

DOI

PubMed

Copy reference

Clinical Pharmacology and Therapeutics

Lingas G et al.Lingas G, Planas D, Péré H, Porrot F, Guivel-Benhassine F, Staropoli I, Duffy D, Chapuis N, Gobeaux C, Veyer D, Delaugerre C, Le Goff J, Getten P, Hadjadj J, Bellino A, Parfait B, Treluyer JM, Schwartz O, Guedj J, Kernéis S, Terrier B

Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial

2024

DOI

PubMed

Copy reference

The Journal of Antimicrobial Chemotherapy

Beaulieu M et al.Beaulieu M, Gaymard A, Massonnaud C, Peiffer-Smadja N, Bouscambert-Duchamp M, Carcelain G, Lingas G, Mentré F, Ader F, Hites M, Poignard P, Guedj J

Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages

2024

DOI

PubMed

Copy reference

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie

Driouich JS et al.Driouich JS, Cochin M, Lingas G, Luciani L, Baronti C, Bernadin O, Gilles M, Villarroel PMS, Moureau G, Petit PR, Dupont A, Izopet J, Kamar N, Autran B, Paintaud G, Caillard S, le Bourgeois A, Richez C, Couzi L, Xhaard A, Marjanovic Z, Avouac J, Jacquet C, Anglicheau D, Cheminant M, Nguyen S, Terrier B, Gottenberg JE, Besson C, Letrou S, Tine J, Basilua JM, Angoulvant D, Tardivon C, Blancho G, Martin-Blondel G, Yazdanpanah Y, Mentré F, Lévy V, Touret F, Guedj J, de Lamballerie X, Nougairède A

High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients

2023

DOI

PubMed

Copy reference

Journal of Medical Virology

Chenane HR et al.Chenane HR, Lingas G, Menidjel R, Laouenan C, Tubiana S, Descamps D, Le Hingrat Q, Abel L, Guedj J, Malhotra S, Kumar-Singh S, Visseaux B, Ghosn J, Charpentier C, Lebourgeois S, French COVID Cohort Study Group

Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients

2023

DOI

PubMed

Copy reference

CPT: pharmacometrics & systems pharmacology

Néant N et al.Néant N, Lingas G, Gaymard A, Belhadi D, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Bouscambert-Duchamp M, Gagneux-Brunon A, Ader F, Mentré F, Wallet F, Burdet C, Guedj J, DisCoVeRy study group

Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial

2022

DOI

PubMed

Copy reference

The Journal of Antimicrobial Chemotherapy

Lingas G et al.Lingas G, Néant N, Gaymard A, Belhadi D, Peytavin G, Hites M, Staub T, Greil R, Paiva JA, Poissy J, Peiffer-Smadja N, Costagliola D, Yazdanpanah Y, Wallet F, Gagneux-Brunon A, Mentré F, Ader F, Burdet C, Guedj J, Bouscambert-Duchamp M

Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates

2022

DOI

PubMed

Copy reference

Nature Communications

Marlin R et al.Marlin R, Desjardins D, Contreras V, Lingas G, Solas C, Roques P, Naninck T, Pascal Q, Behillil S, Maisonnasse P, Lemaitre J, Kahlaoui N, Delache B, Pizzorno A, Nougairede A, Ludot C, Terrier O, Dereuddre-Bosquet N, Relouzat F, Chapon C, Ho Tsong Fang R, van der Werf S, Rosa Calatrava M, Malvy D, de Lamballerie X, Guedj J, Le Grand R

Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort

2021

DOI

PubMed

Copy reference

Proceedings of the National Academy of Sciences of the United States of America

Néant N et al.Néant N, Lingas G, Le Hingrat Q, Ghosn J, Engelmann I, Lepiller Q, Gaymard A, Ferré V, Hartard C, Plantier JC, Thibault V, Marlet J, Montes B, Bouiller K, Lescure FX, Timsit JF, Faure E, Poissy J, Chidiac C, Raffi F, Kimmoun A, Etienne M, Richard JC, Tattevin P, Garot D, Le Moing V, Bachelet D, Tardivon C, Duval X, Yazdanpanah Y, Mentré F, Laouénan C, Visseaux B, Guedj J, French COVID Cohort Investigators and French Cohort Study groups

Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model

2021

Copy reference

Nature communications

Driouich JS et al.Driouich JS, Cochin M, Lingas G, Moureau G, Touret F, Petit PR, Piorkowski G, Barthélémy K, Laprie C, Coutard B

Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model

2021

Copy reference

Nature communications

Driouich JS et al.Driouich JS, Cochin M, Lingas G, Moureau G, Touret F, Petit PR, Piorkowski G, Barthélémy K, Laprie C, Coutard B

Survival of SARS-CoV-2 on Non-Porous Materials in an Experimental Setting Representative of Fomites

2021

DOI

Copy reference

Coatings

Bonil L et al.Bonil L, Lingas G, Coupeau D, Lucet JC, Guedj J, Visseaux B, Muylkens B

Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin

2021

DOI

PubMed

Copy reference

PLoS computational biology

Lingas G et al.Lingas G, Rosenke K, Safronetz D, Guedj J